These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 36217943)

  • 21. Quantitative proteomics of hamster lung tissues infected with SARS-CoV-2 reveal host factors having implication in the disease pathogenesis and severity.
    Suresh V; Mohanty V; Avula K; Ghosh A; Singh B; Reddy RK; Parida D; Suryawanshi AR; Raghav SK; Chattopadhyay S; Prasad P; Swain RK; Dash R; Parida A; Syed GH; Senapati S
    FASEB J; 2021 Jul; 35(7):e21713. PubMed ID: 34105201
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proteomics and Machine Learning Approaches Reveal a Set of Prognostic Markers for COVID-19 Severity With Drug Repurposing Potential.
    Suvarna K; Biswas D; Pai MGJ; Acharjee A; Bankar R; Palanivel V; Salkar A; Verma A; Mukherjee A; Choudhury M; Ghantasala S; Ghosh S; Singh A; Banerjee A; Badaya A; Bihani S; Loya G; Mantri K; Burli A; Roy J; Srivastava A; Agrawal S; Shrivastav O; Shastri J; Srivastava S
    Front Physiol; 2021; 12():652799. PubMed ID: 33995121
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proteomics of SARS-CoV-2-infected host cells reveals therapy targets.
    Bojkova D; Klann K; Koch B; Widera M; Krause D; Ciesek S; Cinatl J; Münch C
    Nature; 2020 Jul; 583(7816):469-472. PubMed ID: 32408336
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Randomized Open label Phase-II Clinical Trial with or without Infusion of Plasma from Subjects after Convalescence of SARS-CoV-2 Infection in High-Risk Patients with Confirmed Severe SARS-CoV-2 Disease (RECOVER): A structured summary of a study protocol for a randomised controlled trial.
    Janssen M; Schäkel U; Djuka Fokou C; Krisam J; Stermann J; Kriegsmann K; Haberbosch I; Novotny JP; Weber S; Vehreschild M; Bornhäuser M; Bullinger L; Schmitt M; Liebregts T; Dreger P; Lorenz HM; Plaszczyca A; Bartenschlager R; Müller B; Kräusslich HG; Halama N; Jäger D; Schlenk RF; Leo A; Meuer S; Weigand MA; Motsch J; Merle U; Denkinger CM; Müller-Tidow C
    Trials; 2020 Oct; 21(1):828. PubMed ID: 33023671
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SARS-CoV-2 immune repertoire in MIS-C and pediatric COVID-19.
    Ravichandran S; Tang J; Grubbs G; Lee Y; Pourhashemi S; Hussaini L; Lapp SA; Jerris RC; Singh V; Chahroudi A; Anderson EJ; Rostad CA; Khurana S
    Nat Immunol; 2021 Nov; 22(11):1452-1464. PubMed ID: 34611361
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma Proteome Fingerprints Reveal Distinctiveness and Clinical Outcome of SARS-CoV-2 Infection.
    Bauer W; Weber M; Diehl-Wiesenecker E; Galtung N; Prpic M; Somasundaram R; Tauber R; Schwenk JM; Micke P; Kappert K
    Viruses; 2021 Dec; 13(12):. PubMed ID: 34960725
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization by Quantitative Serum Proteomics of Immune-Related Prognostic Biomarkers for COVID-19 Symptomatology.
    Villar M; Urra JM; Rodríguez-Del-Río FJ; Artigas-Jerónimo S; Jiménez-Collados N; Ferreras-Colino E; Contreras M; de Mera IGF; Estrada-Peña A; Gortázar C; de la Fuente J
    Front Immunol; 2021; 12():730710. PubMed ID: 34566994
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ultra-Sensitive Serial Profiling of SARS-CoV-2 Antigens and Antibodies in Plasma to Understand Disease Progression in COVID-19 Patients with Severe Disease.
    Ogata AF; Maley AM; Wu C; Gilboa T; Norman M; Lazarovits R; Mao CP; Newton G; Chang M; Nguyen K; Kamkaew M; Zhu Q; Gibson TE; Ryan ET; Charles RC; Marasco WA; Walt DR
    Clin Chem; 2020 Dec; 66(12):1562-1572. PubMed ID: 32897389
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Accurate Diagnosis of COVID-19 by a Novel Immunogenic Secreted SARS-CoV-2 orf8 Protein.
    Wang X; Lam JY; Wong WM; Yuen CK; Cai JP; Au SW; Chan JF; To KKW; Kok KH; Yuen KY
    mBio; 2020 Oct; 11(5):. PubMed ID: 33082264
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Understanding COVID-19 via comparative analysis of dark proteomes of SARS-CoV-2, human SARS and bat SARS-like coronaviruses.
    Giri R; Bhardwaj T; Shegane M; Gehi BR; Kumar P; Gadhave K; Oldfield CJ; Uversky VN
    Cell Mol Life Sci; 2021 Feb; 78(4):1655-1688. PubMed ID: 32712910
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SARS-CoV-2/human interactome reveals ACE2 locus crosstalk with the immune regulatory network in the host.
    Lite C; Ahmed SSSJ; Juliet M; Freddy AJ
    Pathog Dis; 2021 Feb; 79(2):. PubMed ID: 33469663
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proteomics and Informatics for Understanding Phases and Identifying Biomarkers in COVID-19 Disease.
    Whetton AD; Preston GW; Abubeker S; Geifman N
    J Proteome Res; 2020 Nov; 19(11):4219-4232. PubMed ID: 32657586
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Longitudinal proteomic profiling provides insights into host response and proteome dynamics in COVID-19 progression.
    Lee JS; Han D; Kim SY; Hong KH; Jang MJ; Kim MJ; Kim YG; Park JH; Cho SI; Park WB; Lee KB; Shin HS; Oh HS; Kim TS; Park SS; Seong MW
    Proteomics; 2021 Jun; 21(11-12):e2000278. PubMed ID: 33945677
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma Proteins Associated with COVID-19 Severity in Puerto Rico.
    Rosario-Rodríguez LJ; Cantres-Rosario YM; Carrasquillo-Carrión K; Rosa-Díaz A; Rodríguez-De Jesús AE; Rivera-Nieves V; Tosado-Rodríguez EL; Méndez LB; Roche-Lima A; Bertrán J; Meléndez LM
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791465
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-resolution serum proteome trajectories in COVID-19 reveal patient-specific seroconversion.
    Geyer PE; Arend FM; Doll S; Louiset ML; Virreira Winter S; Müller-Reif JB; Torun FM; Weigand M; Eichhorn P; Bruegel M; Strauss MT; Holdt LM; Mann M; Teupser D
    EMBO Mol Med; 2021 Aug; 13(8):e14167. PubMed ID: 34232570
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lost in deletion: The enigmatic ORF8 protein of SARS-CoV-2.
    Zinzula L
    Biochem Biophys Res Commun; 2021 Jan; 538():116-124. PubMed ID: 33685621
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of Multiomics Data to Understand Host-Pathogen Interactions in COVID-19 Pathogenesis.
    Aggarwal S; Acharjee A; Mukherjee A; Baker MS; Srivastava S
    J Proteome Res; 2021 Feb; 20(2):1107-1132. PubMed ID: 33426872
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A proteome-scale map of the SARS-CoV-2-human contactome.
    Kim DK; Weller B; Lin CW; Sheykhkarimli D; Knapp JJ; Dugied G; Zanzoni A; Pons C; Tofaute MJ; Maseko SB; Spirohn K; Laval F; Lambourne L; Kishore N; Rayhan A; Sauer M; Young V; Halder H; la Rosa NM; Pogoutse O; Strobel A; Schwehn P; Li R; Rothballer ST; Altmann M; Cassonnet P; Coté AG; Vergara LE; Hazelwood I; Liu BB; Nguyen M; Pandiarajan R; Dohai B; Coloma PAR; Poirson J; Giuliana P; Willems L; Taipale M; Jacob Y; Hao T; Hill DE; Brun C; Twizere JC; Krappmann D; Heinig M; Falter C; Aloy P; Demeret C; Vidal M; Calderwood MA; Roth FP; Falter-Braun P
    Nat Biotechnol; 2023 Jan; 41(1):140-149. PubMed ID: 36217029
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of a multiomics model for identification of predictive biomarkers for COVID-19 severity: a retrospective cohort study.
    Byeon SK; Madugundu AK; Garapati K; Ramarajan MG; Saraswat M; Kumar-M P; Hughes T; Shah R; Patnaik MM; Chia N; Ashrafzadeh-Kian S; Yao JD; Pritt BS; Cattaneo R; Salama ME; Zenka RM; Kipp BR; Grebe SKG; Singh RJ; Sadighi Akha AA; Algeciras-Schimnich A; Dasari S; Olson JE; Walsh JR; Venkatakrishnan AJ; Jenkinson G; O'Horo JC; Badley AD; Pandey A
    Lancet Digit Health; 2022 Sep; 4(9):e632-e645. PubMed ID: 35835712
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.